<code id='12D13140A0'></code><style id='12D13140A0'></style>
    • <acronym id='12D13140A0'></acronym>
      <center id='12D13140A0'><center id='12D13140A0'><tfoot id='12D13140A0'></tfoot></center><abbr id='12D13140A0'><dir id='12D13140A0'><tfoot id='12D13140A0'></tfoot><noframes id='12D13140A0'>

    • <optgroup id='12D13140A0'><strike id='12D13140A0'><sup id='12D13140A0'></sup></strike><code id='12D13140A0'></code></optgroup>
        1. <b id='12D13140A0'><label id='12D13140A0'><select id='12D13140A0'><dt id='12D13140A0'><span id='12D13140A0'></span></dt></select></label></b><u id='12D13140A0'></u>
          <i id='12D13140A0'><strike id='12D13140A0'><tt id='12D13140A0'><pre id='12D13140A0'></pre></tt></strike></i>

          hotspot

          hotspot

          author:leisure time    Page View:8
          Zepbound, a injectable drug on a gradient background of dark purple and green — biotech coverage from STAT
          Illustration: STAT; Source: Eli Lilly/AP

          A California biotech developing a combination therapy with the obesity drug Zepbound has raised a $170 million Series D round.

          The company, BioAge, raised money from more than a dozen investors. Sofinnova Investments led the round, which also included Eli Lilly and Amgen’s venture arms and previous investor Andreessen Horowitz.

          advertisement

          BioAge’s primary focus is in developing medications that boost a person’s healthspan, or the number of healthy years a person lives. The company has drugs in development for neuroinflammation and brain aging. But the majority of the Series D proceeds will be used to develop the company’s lead drug candidate azelaprag, which is being tested in combination with Zepbound. That drug program is what grabbed Sofinnova’s attention, according to managing partner Jim Healy, who recently became chairman of BioAge’s board.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

          AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

          read more
          Obesity drug from Roche shows promise in early study
          Obesity drug from Roche shows promise in early study

          SebastienBozon/AFPviaGettyImagesLONDON—RocheonThursdaysaiditsrecentlyacquiredexperimentalobesitymedi

          read more
          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more

          Presidential fundraising highlights so far: Trump brings in more than DeSantis

          12:29Republicanpresidentialcandidate,formerPresidentDonaldTrumpstandsonstageafterbeingintroducedduri